A novel NiCaAl-LDH@ND-COOH nanocomposite-modified electrode for highly sensitive and selective electrochemical detection of larotrectinib in pharmaceutical and biological samples
- PMID: 40856872
- DOI: 10.1007/s00604-025-07476-4
A novel NiCaAl-LDH@ND-COOH nanocomposite-modified electrode for highly sensitive and selective electrochemical detection of larotrectinib in pharmaceutical and biological samples
Abstract
A novel electrochemical sensor based on a glassy carbon electrode (GCE) modified with a NiCaAl layered double hydroxide with carboxyl-functionalized nanodiamonds (NiCaAl-LDH@ND-COOH) was developed for the first time to enable sensitive and selective detection of larotrectinib (LARO), the first selective pan-tropomyosin receptor kinase (TRK) inhibitor used clinically for cancer treatment. The nanocomposite was synthesized by integrating NiCaAl layered double hydroxide (LDH) with carboxyl-functionalized nanodiamonds (ND-COOH), resulting in enhanced electrocatalytic performance. The individual electrochemical properties of ND-COOH and NiCaAl-LDH were systematically evaluated and compared with those of the combined nanocomposite. ND-COOH contributed high surface area, low background current, and improved conductivity, while NiCaAl-LDH offered abundant redox-active sites and high ion-exchange capacity. The NiCaAl-LDH@ND-COOH nanocomposite exhibited a synergistic enhancement in electron transfer kinetics and surface activity, as evidenced by cyclic voltammetry and impedance studies. Under optimized conditions, the sensor displayed a wide linear detection range (1.0 to 16.37 µM) and a low detection limit of 4.36 nM. It also demonstrated excellent repeatability (RSD = 1.3%), reproducibility (RSD = 1.23%), and high selectivity against common interferents. Successful application to pharmaceutical formulations, serum, and urine samples confirmed its practicality, achieving recoveries between 96.7% and 102.6%. This work provides the first electrochemical sensing platform for LARO, offering a reliable and cost-effective tool for its monitoring in clinical and pharmaceutical settings.
Keywords: Differential pulse voltammetry; Electrochemical sensor; Larotrectinib detection; Modified glassy carbon electrode; NiCaAl-LDH@ND-COOH nanocomposite; Pharmaceutical samples; Trace analysis.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval: No approval of research ethics committees was required to accomplish the goals of this study because synthetic materials were used in the experimental study. Conflict of interest: The authors declare no competing interests. Clinical trial number: Not applicable.
Similar articles
-
Electrochemical detection of agomelatine using a high-performance FeZn LDH/graphene/polyaniline nanocomposite sensor for clinical and pharmaceutical analysis.Mikrochim Acta. 2025 Aug 16;192(9):595. doi: 10.1007/s00604-025-07461-x. Mikrochim Acta. 2025. PMID: 40817945
-
A novel MIP electrochemical sensor based on a CuFe2O4NPs@rGO nanocomposite and its application in breast milk samples for the determination of fipronil.Anal Methods. 2025 Jul 3;17(26):5508-5518. doi: 10.1039/d5ay00911a. Anal Methods. 2025. PMID: 40557723
-
Voltammetric analysis of epinephrine using glassy carbon electrode modified with nanocomposite prepared from Co-Nd bimetallic nanoparticles, alumina nanoparticles and functionalized multiwalled carbon nanotubes.Environ Sci Pollut Res Int. 2023 Dec;30(60):124866-124883. doi: 10.1007/s11356-022-23660-y. Epub 2022 Oct 25. Environ Sci Pollut Res Int. 2023. PMID: 36280636 Free PMC article.
-
Ultra-sensitive electrochemical sensor based on molecularly imprinted polydopamine grafted with MWCNT-COOH for tryptophan detection.Mikrochim Acta. 2025 Jul 21;192(8):506. doi: 10.1007/s00604-025-07329-0. Mikrochim Acta. 2025. PMID: 40690029
-
Recent Progress in Electrocatalysts for Hydroquinone Electrochemical Sensing Application.Biosensors (Basel). 2025 Jul 28;15(8):488. doi: 10.3390/bios15080488. Biosensors (Basel). 2025. PMID: 40862949 Free PMC article. Review.
References
-
- Numakawa T, Odaka H (2023) Roles of Trk receptors, tyrosine kinase receptors for neurotrophins. the developing CNS, in Receptor tyrosine kinases in neurodegenerative and psychiatric disorders. Elsevier, pp 79–115
-
- Amatu A, Sartore-Bianchi A, Siena S (2016) NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open 1(2):e000023
-
- Gambella A et al (2020) NTRK fusions in central nervous system tumors: a rare, but worthy target. Int J Mol Sci 21(3):753
-
- Chetty R (2019) Neurotrophic tropomyosin or t yrosine receptor kinase (NTRK) genes. J Clin Pathol 72(3):187–190
-
- Aljehani, M.R., et al., The importance of histopathological evaluation in cancer diagnosis and treatment. International journal of health sciences. 7(S1): p. 3614–3623.